DIN 02456222 — TAGRISSO 80 MG
TAGRISSO is a tablet of Osimertinib marketed by ASTRAZENECA CANADA INC. The full Osimertinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456222
- Brand name
- TAGRISSO
- Active ingredient
- Osimertinib
- Strength
- 80 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Osimertinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02456214 | TAGRISSO | 40 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |